Venlafaxine-induced hepatotoxicity in a patient with ulcerative colitis.
Beytullah
B
Yildirim
Candan
C
Tuncer
Meltem
M
Ergun
Selahattin
S
Unal
D000469:Alkaline Phosphatase / Q000097:blood; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis*; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000175:diagnosis*; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000188:drug therapy; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D008875:Middle Aged; D000069470:Venlafaxine Hydrochloride; D005723:gamma-Glutamyltransferase / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D019804:Mesalamine; D000069470:Venlafaxine Hydrochloride; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase